Clinical Trial Update: A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial update for MAU868 assessing safety, pharmacokinetics, and efficacy in BK virus infection among kidney transplant recipients has completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection
• Kidney Transplant Complication

Drugs mentioned

• MAU868 (MAU868)

Snippet

Sponsor: Vera Therapeutics, Inc. | Conditions: BK Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24